Clostridium difficile infection

Annals of Internal Medicine

Volumn 153, Issue 7, 2010, Pages

  Turner, Barbara J ^a   Williams, Sankey ^a   Taichman, Darren ^a   Hessen, Margaret Trexler ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTINEOPLASTIC AGENT; BACITRACIN; CEPHALOSPORIN; CLAVULANIC ACID; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN B; COLESTIPOL; COLESTYRAMINE; CREATININE; CYTOTOXIN; ERYTHROMYCIN; GLUTAMATE DEHYDROGENASE; METRONIDAZOLE; PENICILLIN G; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; BACTERIAL COLONIZATION; BACTERIAL SPORE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BLOOD CELL COUNT; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON PERFORATION; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CONSULTATION; DIAGNOSTIC TEST; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DYSGEUSIA; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEVER; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HAND WASHING; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LONG TERM CARE; MALABSORPTION; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; PATIENT MONITORING; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RECURRENT INFECTION; REVIEW; SEIZURE; SENESCENCE; TOXIC MEGACOLON; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; CLOSTRIDIUM DIFFICILE; ISOLATION AND PURIFICATION; MICROBIOLOGY; RISK FACTOR;

ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INFECTION CONTROL; RISK FACTORS;

EID: 78349248598     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S12-8. [PMID: 18177217]
2. Ricciardi R, Rothenberger DA, Madoff RD, et al. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007;142:624-31; discussion 631. [PMID: 17638799]
3. Jarvis WR, Schlosser J, Jarvis AA, et al. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control. 2009;37:263-70. [PMID: 19278754]
4. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442-9. [PMID: 16322602]
5. Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk - four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201-5. [PMID: 16319813]
6. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile - Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:340-3. [PMID: 18385641]
7. Fekety R, Kim KH, Brown D, et al. Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med. 1981;70:906-8. [PMID: 7211925]
8. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204-10. [PMID: 2911306]
9. Rodriguez-Palacios A, Staempfli HR, Duffield T, et al. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis. 2007;13:485-7. [PMID: 17552108]
10. Yaeger MJ, Kinyon JM, Glenn Songer J. A prospective, case control study evaluating the association between Clostridium difficile toxins in the colon of neonatal swine and gross and microscopic lesions. J Vet Diagn Invest. 2007;19:52-9. [PMID: 17459832]
11. SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol. 2002;23:696-703. [PMID: 12452300]
12. Thielman NM, Wilson KH. Antibiotic-associated colitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, seventh edition. Philadelphia: Churchill Livingstone; 2010:1375-87.
13. Owens RC Jr, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S19-31. [PMID: 18177218]
14. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273-80. [PMID: 15796280]
15. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis. 1993;17:109-13. [PMID: 8353229]
16. Shah S, Lewis A, Leopold D, et al. Gastric acid suppression does not promote clostridial diarrhoea in the elderly. QJM. 2000;93:175-81. [PMID: 10751237]
17. Dial S, Delaney JA, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989-95. [PMID: 16414946]
18. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162:678-84. [PMID: 2387993]
19. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol. 1991;12:345-8. [PMID: 2071877]
20. Bliss DZ, Johnson S, Savik K, et al. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129:1012-9. [PMID: 9867755]
21. Kyne L, Sougioultzis S, McFarland LV, et al. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002;23:653-9. [PMID: 12452292]
22. Fowler S, Webber A, Cooper BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother. 2007;59:990-5. [PMID: 17387117]
23. Valiquette L, Cossette B, Garant MP, et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112-21. [PMID: 17683015]
24. Perry C, Marshall R, Jones E. Bacterial contamination of uniforms. J Hosp Infect. 2001;48:238-41. [PMID: 11439013]
25. Society for Healthcare Epidemiology of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-55. [PMID: 20307191]
26. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med. 1990;88:137-40. [PMID: 2301439]
27. Oughton MT, Loo VG, Dendukuri N, et al. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol. 2009;30:939-44. [PMID: 19715426]
28. Gordin FM, Schultz ME, Huber RA, et al. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol. 2005;26:650-3. [PMID: 16092747]
29. Rupp ME, Fitzgerald T, Puumala S, et al. Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units . Infect Control Hosp Epidemiol. 2008;29:8-15. [PMID: 18171181]
30. Dial S, Kezouh A, Dascal A, et al. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179:767-72. [PMID: 18838451]
31. National Clostridium difficile Standards Group. Report to the Department of Health. J Hosp Infect. 2004;56 Suppl 1:1-38. [PMID: 15129935]
32. Delmée M, Van Broeck J, Simon A, et al. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol. 2005;54:187-91. [PMID: 15673515]
33. Peterson LR, Manson RU, Paule SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis. 2007;45:1152-60. [PMID: 17918076]
34. Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann Intern Med. 2009;151:176-9. [PMID: 19652187]
35. Johal SS, Hammond J, Solomon K, et al. Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut. 2004;53:673-7. [PMID: 15082585]
36. Tedesco FJ, Corless JK, Brownstein RE. Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology. 1982;83:1259-60. [PMID: 7129030]
37. Seppälä K, Hjelt L, Sipponen P. Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study. Scand J Gastroenterol. 1981;16:465-8. [PMID: 7323683]
38. Pépin J, Valiquette L, Alary ME, et al. Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466-72. [PMID: 15337727]
39. Bulusu M, Narayan S, Shetler K, et al. Leucocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol. 2000;95:3137-41. [PMID: 11095331]
40. Wanahita A, Goldsmith EA, Marino BJ, et al. Clostridium difficile infection in patients with unexplained leucocytosis. Am J Med. 2003;115:543-6. [PMID: 14599633]
41. Lamontagne F, Labbé AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245:267-72. [PMID: 17245181]
42. Ash L, Baker ME, O'Malley CM Jr, et al. Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. AJR Am J Roentgenol. 2006;186:1393-400. [PMID: 16632736]
43. Olson MM, Shanholtzer CJ, Lee JT Jr, et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol. 1994;15:371-81. [PMID: 7632199]
44. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302-7. [PMID: 17599306]
45. Pépin J, Routhier S, Gagnon S, et al. Management and outcomes of a first recurrence of Clostridium difficileassociated disease in Quebec, Canada. Clin Infect Dis. 2006;42:758-64. [PMID: 16477549]
46. Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986;27:1169-72. [PMID: 3781329]
47. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficileassociated diarrhoea and colitis. Lancet. 1983;2:1043-6. [PMID: 6138597]
48. Wenisch C, Parschalk B, Hasenhündl M, et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis. 1996;22:813-8. [PMID: 8722937]
49. Nelson R. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2007:CD004610. [PMID: 17636768]
50. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005;40:1586-90. [PMID: 15889354]
51. Belmares J, Gerding DN, Parada JP, et al. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect. 2007;55:495-501. [PMID: 17983659]
52. Al-Nassir WN, Sethi AK, Nerandzic MM, et al. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis. 2008;47:56-62. [PMID: 18491964]
53. Bartlett JG. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46:1489-92. [PMID: 18419480]
54. Louie T. Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in Clostridium difficile-associated diarrhea (CDAD) [Abstract]. Program and abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington DC). Herndon, VA: ASM Press; 2007. Abstract no. K-4259.
55. Pillai A, Nelson R. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev. 2008:CD004611. [PMID: 18254055]
56. Schwan A, Sjölin S, Trottestam U, et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis. 1984;16:211-5. [PMID: 6740251]
57. Gustafsson A, Lund- Tønnesen S, Berstad A, et al. Faecal shortchain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol. 1998;33:721-7. [PMID: 9712236]
58. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580-5. [PMID: 12594638]
59. Koss K, Clark MA, Sanders DS, et al. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006;8:149-54. [PMID: 16412077]
60. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol. 1985;80:867-8. [PMID: 4050760]
61. Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Accessed at www.cdc.gov/hicpac/2007ip/2007isolationprecautions.html on 18 August 2010.